Skip to main content
SpringerLink
Log in

Non-Chemotherapeutic Approaches to Uncontrolled CNS Tumors

  • Chapter
Pediatric Oncology 1

Part of the book series: Cancer Treatment and Research ((CTAR,volume 2))

  • 91 Accesses

Abstract

The American Cancer Society predicted that there would be 11,900 new cases of primary central nervous system cancers and 9800 deaths in the U.S. during 1980 [1]. Tumors of the central nervous system are the second most common cancer in children of both sexes under the age of 15 years, surpassed only by the incidence of leukemias. The etiology of intracranial tumors is unknown, although trauma has often been discussed as a possible cause [2–4], even though there is, as yet, no clear demonstration that trauma is involved in the generation of primary brain cancers. A few relatively rare forms of central nervous system tumors such as acoustic neuromas and neurofibromas appear to follow hereditary patterns. Different forms of primary brain cancers have different biological, kinetic and metabolic characteristics, making it difficult to discuss the oncology of this organ site as a single entity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Cancer Society, Cancer facts and figures 1980. New York: American Cancer Society, p 9.

    Google Scholar 

  2. Annegers JF, Laws ER, Kurland LT, Grabow JD: Head trauma and subsequent brain tumors. Neurosurgery 4: 203–206, 1979.

    Article  CAS  PubMed  Google Scholar 

  3. Cushing H, Eisankardt L: Meningiomas: their classification, regional behavior, life history and surgical end results. Springfield, Ill.: Charles C. Thomas, 1938.

    Google Scholar 

  4. Parker HL, Kernohan JW: The relation of injury and glioma of the brain. J Am Med Assoc 97: 535–540, 1931.

    Google Scholar 

  5. Wilson CB, Boldery EB, Enot KJ: Bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors. Cancer Chemother Rep 54: 273–281, 1970

    CAS  PubMed  Google Scholar 

  6. Venes JL, Mcintosh S, O’Brien RT, Schwartz AD: Chemotherapy as an adjunct in the initial management of cerebellar medulloblastoma. J Neurosurg 50: 721–724, 1979.

    Article  CAS  PubMed  Google Scholar 

  7. Crafts DC, Levin VA, Edwards MS, Pisher TL, Wilson CB: Chemotherapy of recurrent medulloblastoma with combined procarbazine. CCNU and vincristine. J Neurosurg 49: 589–592, 1978.

    Article  CAS  PubMed  Google Scholar 

  8. Farwell JR, Dohrmann GJ, Marrett LD, Mergs JW: Effect of SV40 virus-contaminated folio vaccine on the incidence and type of CNS neoplasms in children. Ann Neurol 6: 166–167, 1979.

    Google Scholar 

  9. Russell DS, Rubinstein LJ: Pathology of tumors of the nervous system, 3rd edn. London: Edward Arnold, 1970.

    Google Scholar 

  10. Walker MD, Hunt WE, Mahaley MS, Norrell HA, Ransohoff J, Gehan EA: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49: 333–343, 1978.

    Article  CAS  PubMed  Google Scholar 

  11. Kusske JA, Williams JP, Garcia JH, Pribram HW: Radiation necrosis of the brain following radiotherapy of extracerebral neoplasms. Surg Neurol 6: 15–20, 1976.

    CAS  PubMed  Google Scholar 

  12. Sogg RL, Donaldson SS, Yorke CH: Malignant astrocytoma following radiotherapy of a craniopharyngioma. J Neurosurg 48: 622–627, 1978.

    Article  CAS  PubMed  Google Scholar 

  13. Caveness WF: Pathology of radiation damage to the normal brain of the monkey. Natl Cancer Inst Monogr 46: 57–76, 1976.

    Google Scholar 

  14. Shapiro WR: Management of primary malignant brain tumors. Neurol Neurosurg Update. Princeton, N.J.: Biomedia, 1978.

    Google Scholar 

  15. Hologe PY, Jenkins EE, Greenberg SD: Pulmonary toxicity in long term administration of BCNU. Cancer Treatment Rep 60: 1691–1694, 1976.

    Google Scholar 

  16. Jones MPH, Marsden HB, Bailey CC: Fatal pulmonary fibrosis following 1,3-bis (2-chloroethyl)-nitrosourea (BCNU) therapy. Cancer 42: 74–76, 1978.

    Article  PubMed  Google Scholar 

  17. Munro HM: Tumor-host competition for nutrients in the cancer patient. J Am Dietetic Assoc 71: 380–384, 1977.

    CAS  Google Scholar 

  18. White FR, Belkin M: Source of tumor protein. I: Effect of a low-nitrogen diet on the establishment and growth of a transplanted tumor. J Natl Cancer Inst 5: 261–263, 1945.

    CAS  Google Scholar 

  19. White ER: Source of tumor proteins. II: Nitrogen-balance studies of tumor bearing mice fed a low nitrogen diet. J Natl Cancer Inst 5: 265–270, 1945.

    CAS  Google Scholar 

  20. Sherman CD Jr, Morton JJ, Midler GB: Potential sources of tumor nitrogen. Cancer Res 10: 374–378, 1950.

    CAS  PubMed  Google Scholar 

  21. Babson AL: Some host-tumor relationships with respect to nitrogen. Cancer Res 14: 89–93, 1954.

    CAS  PubMed  Google Scholar 

  22. Skipper HE, Thomson JR: Amino acids and peptides with antimetabolic activity. Boston: Little Brown, 1958, pp 38–53.

    Google Scholar 

  23. Sugimura T, Birnbaum SM, Winitz M, Greenstein JP: Quantitative nutritional studies with water-soluble, chemically defined diets. VII. The forced feeding of diets lacking one essential amino Acid. Arch Biochem Biophys 81: 448–455, 1959.

    Article  CAS  PubMed  Google Scholar 

  24. Lorincz AB, Kuttner RE, Brandt MB: Tumor response to PHE-TYR limited diets. J Am Dietetic Assoc 54: 198–205, 1969.

    CAS  Google Scholar 

  25. Demopoulos HB: Effects of low phenylalanine-tryrosine diets on S 91 mouse melanomas. J Natl Cancer Inst 37: 185–190, 1966.

    CAS  PubMed  Google Scholar 

  26. Demopoulos HB: Effects of reducing the phenylalanine-tyrosine intake of patients with advanced malignant melanoma. Cancer 19: 657–664, 1966.

    Article  CAS  PubMed  Google Scholar 

  27. Theuer RC: Effect of essential amino acid restriction on the growth of female C57BL mice and their implanted BW 10232 adenocarcinomas. J Nutr 101: 223–232, 1971.

    CAS  PubMed  Google Scholar 

  28. Pine MJ: Effect of low phenylalanine diet on murine leukemia L1210. J Natl Cancer Inst 60: 633–641, 1978.

    CAS  PubMed  Google Scholar 

  29. Jose DJ, Good RA: Quantitative effects of nutritional essential amino acid deficiency upon immune responses to tumors in mice. J Exp Med 137: 1–9, 1972.

    Article  Google Scholar 

  30. Worthington BS, Syrotock JA, Ahmed SI: Effects of essential amino acid deficiencies on syngeneic tumor immunity and carcinogenesis in mice. J Nutr 108: 1402–1411, 1978.

    CAS  PubMed  Google Scholar 

  31. Lowery SF, Goodgame T, Norton JA, Jones DC, Brennan MF: Effect of chronic protein malnutrition on host-tumor composition and growth. Surg Res 26: 79–86, 1979.

    Article  Google Scholar 

  32. Rogers S, Woodhall B: Rapid method of metabolically characterizing individual tumors. Proc Soc Exp Biol Med 98: 874–877, 1958.

    CAS  PubMed  Google Scholar 

  33. Rogers S, Robertson JT: Biochemical subclassification of astrocytoma grade IV, and its utilization in therapy. Proc Am Assoc Cancer Res 19: 98, 1978.

    Google Scholar 

  34. Spackman DH, Stein WH, Moore S: automatic recording apparatus for use in chromatography of amino acids. Anal Chem 30: 1190–1198, 1958.

    Article  CAS  Google Scholar 

  35. Hamilton PB: Ion exchange chromatography of amino acids—micro determination of free amino acids in serum. Ann N Y Acad Sci 120: 55–67, 1962.

    Google Scholar 

  36. Rose WC: Amino acid requirement of man. Fed Proc 8: 546–552, 1949.

    CAS  PubMed  Google Scholar 

  37. Leverton RM, Gram MR, Chaloupka M, Brodousky E, Mitchel A: The quantitative amino acid requirements of young women, I. Threonine. J Nutr 58: 59–81, 1955.

    Google Scholar 

  38. National Academy of Sciences: Recommended dietary allowances, 8th ed. Washington, DC, 1974, 128 pp.

    Google Scholar 

  39. USDA: Handbook No, 8 revised—composition of foods. Washington, DC.: U S Govt Printing Office, 1963, 190 pp.

    Google Scholar 

  40. Jondal M: In Lymphocytes: isolation, fractionation and characterization, Natvig JB, Perlman P, Wizzel H (eds). Oslo: Universititsforlaget, 1977, pp 69–76.

    Google Scholar 

  41. Young HF, Sakalas R, Kaplan AM: Inoculation of cell-mediated immunity in patients with brain tumors. Surg Neurol 5: 19–23, 1976.

    CAS  PubMed  Google Scholar 

  42. Young HF, Sakalas R, Kaplan AM: Immunologic depression in cerebral gliomas. Adv Neurol 15: 327–335, 1976.

    CAS  PubMed  Google Scholar 

  43. Snyderman R, Pike MC, Altman LC: Abnormalities of leukocyte Chemotaxis in human disease. Ann NY Acad Sci 256: 386–392, 1974.

    Article  Google Scholar 

  44. Snyderman R, Pike MC: An inhibitor of macrophage Chemotaxis produced by neoplasms. Science 192: 370–373, 1976.

    Article  CAS  PubMed  Google Scholar 

  45. Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF: Nutritional and metabolic assessment of the hospitalized patient. J Parenteral Enteral Nutr 1: 11–22, 1977.

    Article  CAS  Google Scholar 

  46. Gurney JM, Jelliffe DB: Arm anthropometry in nutritional assessment: nomogram for rapid calculation of muscle circumference and cross-sectional muscle and fat areas. Am J Clin Nutr 26: 912–915, 1973.

    CAS  PubMed  Google Scholar 

  47. Bergstrom J, Furst P, Josephson B, Norée LO: Factors affecting the nitrogen balance in chronic uremic patients receiving essential amino acids intravenously or by mouth. Nutr Metabol 14 (Suppl): 162–170, 1972.

    Article  Google Scholar 

  48. Kopple JD, Swendseid ME: Evidence that histidine is an essential amino acid in normal and chronically uremic man. J Clin Invest 55: 881–891, 1975.

    Article  CAS  PubMed  Google Scholar 

  49. Anonymous: Histidine: an essential amino acid for normal adults. Nutr Rev 33: 200–202, 1975.

    Google Scholar 

  50. Bertrand I, Mannen H: Etude des reactions vasculaires dans les astrocytomas. Rev Neurol 102: 3–19, 1960.

    Google Scholar 

  51. Ridley A, Cavanaugh JB: Lymphocytic infiltration in gliomas. Evidence of possible host resistance. Brain 94: 117–124, 1971.

    Article  CAS  PubMed  Google Scholar 

  52. Palma L, DiLorenzo N, Grudetti B: Lymphocyte infiltrates in primary glioblastomas and recidivous gliomas. Incidence. fate and relevance to prognosis in 228 operated cases. J Neurosurg 49: 854–861, 1978.

    Article  CAS  PubMed  Google Scholar 

  53. Brooks WH, Markesbery WR, Gupta GD, Roszman TL: Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4: 219–224, 1978.

    Article  CAS  PubMed  Google Scholar 

  54. Young HF, Kaplan AM: Immunotherapy of human gliomas. In: The handbook of cancer immunology, Waters H. (ed.), New York: Garland Press, 1978, pp 357–382.

    Google Scholar 

  55. Cobb JP, Walker DG: Effect of heterologous, homologous and autogenous serums on human normal and malignant cells in vitro. J Natl Cancer Inst 27: 1–9, 1961.

    CAS  PubMed  Google Scholar 

  56. Brooks WH, Netsky MG, Normansell DE, Horwitz DA: Depressed cell-mediated immunity in patients with primary intracranial tumors. J Exp Med 136: 1631–1647, 1972.

    Article  CAS  PubMed  Google Scholar 

  57. Levy NL: Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors. J Immunol 121: 903–915, 1978.

    CAS  PubMed  Google Scholar 

  58. Levy NL: Cell-mediated cytotoxicity and serum mediated blocking: evidence that their associated determinants on human tumor cells are different. J Immunol 121: 916–922, 1978.

    CAS  PubMed  Google Scholar 

  59. Mahaley MS Jr: Immunological considerations and the malignant glioma problem. Clin Neurosurg 15: 175–189, 1968.

    PubMed  Google Scholar 

  60. Bloom HJ, Peckham MJ, Richardson AE, Alexander PA, Payne PM: Glioblastoma Multiforme: A controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer 27: 253–267, 1973.

    Article  CAS  PubMed  Google Scholar 

  61. Ommaya Ak, Albright L: Immunochemotherapy of gliomas. Excerpta Medica Int Congr 293: 314, 1973.

    Google Scholar 

  62. Takakura K, Miki Y, Kubo O, Ogawa N, Matsutani M, Sano K: Adjuvant immunotherapy for malignant brain tumors. Jap J Clin Oncol 12: 109–120, 1972.

    Google Scholar 

  63. Neuwelt EA, Clark K, Kirkpatrick JB, Toben H: Clinical studies of intrathecal autologous lymphocyte infusions in patients with malignant gliomas. A toxicity study. Ann Neurol 4: 307–314, 1978.

    Article  CAS  PubMed  Google Scholar 

  64. Lim R, Kluskens L: Immunological specificity of astrocytoma antigens. Cancer Res 32: 1667–1670, 1972.

    CAS  PubMed  Google Scholar 

  65. Albright L, Madigan JC, Gaston MR, Houchens DP: Therapy in an intracerebral murine glioma model, using Bacillus Calmene Guerin, neuraminidase-treated tumor cells and 1–2-chloroethyl)-3-cyclohexyl-l-nitrososurea. Cancer Res 35: 658–665, 1975.

    CAS  PubMed  Google Scholar 

  66. Neuwelt EA, Doherty D: Toxicity kinetics and clinical potential of subarachnoid lymphocyte infusions. J Neurosurg 47: 205–217, 1977.

    Article  CAS  PubMed  Google Scholar 

  67. Rosenblum MI, Reynolds AF, Smith KA, Rumack BH, Walker MD: Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors. J Neurosurg 39: 306–314, 1973.

    Article  CAS  PubMed  Google Scholar 

  68. Levy NL, Mahaley MS, Day ED: In vitro demonstration of cell-mediated immunity to human brain tumors. Cancer Res 32: 477–482, 1972.

    CAS  PubMed  Google Scholar 

  69. Hellstrom I, Sjogren Ho, Warner G: Blocking of cell-mediated immunity by sera from patients with growing neoplasma. Int J Cancer 7: 226–237, 1971.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. W. L. Banks Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. F. Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. S. Jennings
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. M. Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oklahoma Children’s Memorial Hospital, University of Oklahoma Health Sciences Center, P.O. Box 26901, Oklahoma City, OK, 73190, USA

    G. Bennett Humphrey

  2. Department of Laboratory Medicine and Pathology, Division of Surgical Pathology, University of Minnesota Medical School, Box 609, Mayo Memorial Building, 420 Delaware Street, S.E., Minneapolis, MN, 55455, USA

    Louis P. Dehner

  3. New York State University at Buffalo, USA

    Gerald B. Grindey

  4. Diabetes Research & Training Center, University of Alabama in Birmingham, 1808 Seventh Avenue South, University Station, Birmingham, AL, 35291, USA

    Ronald T. Acton

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Martinus Nijhoff Publishers

About this chapter

Cite this chapter

Banks, W.L., Young, H.F., Jennings, S.S., Kaplan, A.M. (1981). Non-Chemotherapeutic Approaches to Uncontrolled CNS Tumors. In: Humphrey, G.B., Dehner, L.P., Grindey, G.B., Acton, R.T. (eds) Pediatric Oncology 1. Cancer Treatment and Research, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8219-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-8219-2_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-8221-5

  • Online ISBN: 978-94-009-8219-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation